Websites, portals and platforms built for a sector where content has to survive medical, legal and regulatory review.
From a corporate site to a full HCP portal, every build here starts from the same constraint most agencies treat as an afterthought: what your reviewers can approve, what your compliance team requires, and what your team can actually operate once we hand it over.
Most of what we build runs on pharmaceutical WordPress: a real content model and component-based editing your team can operate independently, not a page builder that breaks under real content.
See what a pharma website costs for the real cost drivers behind a quote.
A platform sized to what your team can maintain, whether that is a two-person marketing function or a multi-market enterprise group — see project scoping for how we get to a real number before committing to anything.
A migration or redesign that loses the search visibility your current site earned is a failure regardless of how it looks — every build here accounts for that from the start.
Every web development service we offer, from a first build to a full platform migration.
It is our core platform, built out specifically for pharmaceutical needs such as multi-market content control and MLR-aligned publishing workflows. That said, we do not force every client onto it: where a business already runs on another platform and switching would cost more than it solves, we work within what exists and say so plainly. The platform choice gets confirmed during scoping, not assumed before we have looked at your actual requirements.
Yes, running the site without a developer for every change is the specific goal, not a side benefit. The backend is structured so marketing can create pages, update approved content and manage multi-market variants inside guardrails set at build time. Where a change needs code, that boundary is defined clearly rather than left ambiguous, so your team always knows what they can do themselves versus what needs us.
Both models work, and we do not assume which one fits before asking. We can build a site and hand the finished platform to your internal team, or stay on as the ongoing development partner handling releases and new features. Some clients split it further, keeping day-to-day content with their own team and routing only development work through us. We agree the exact split explicitly during scoping rather than defaulting to one.
Timeline depends mainly on content volume, how many markets and languages are involved, and how many approval rounds the medical and regulatory review adds. A single-market corporate site with existing approved content moves faster than a multi-market platform requiring parallel MLR sign-off in several languages. We size the real driver during scoping rather than quoting a generic range, and the estimate reflects what your specific build requires.
Yes, design and development are scoped together rather than handed between separate teams. The same team that defines the component architecture also designs the interface, which avoids the common gap where a visual design gets approved and then turns out difficult to build inside a compliant, editable platform. Design decisions get tested against technical and regulatory constraints from the start, not adjusted after the fact.
Launch is the start of the relationship, not the end of the project. Most clients move onto an ongoing maintenance arrangement covering updates, monitoring, backups and small content changes, sized to match how critical and how active the site is. Sites left unmaintained after launch tend to accumulate the same problems we get called in to fix on legacy platforms, so we plan for what comes after before the build finishes.
Tell us your situation and we will tell you how we would approach it.